Latest News

View All >>

FDA Grants Orphan Drug Designation to Novel CAR-T Cell Therapy to Treat Waldenstrom Macroglobulinemia, a Rare Type of Cancer

June 27th 2022

By Ryan McDonald

Treatment with the novel CAR-T cell therapy was associated with favorable efficacy and safety results in a group of patients with follicular lymphoma, including a few with Waldenstrom macroglobulinemia, according to findings from a study presented at a recent medical conference.

New Resource ‘Empowers’ Patients With Breast Cancer That Has Spread to the Brain With Much Needed Information

June 27th 2022

By Colleen Moretti

Receiving a diagnosis of metastatic breast cancer that has spread to the brain can be a frightening time for patients, however a new resource may help guide them through the stressful journey.

Cancer Boosted My Empathy, But Anger Is Starting to Rear Its Head

June 27th 2022

By Steve Rubin

After cancer, I now have more empathy for people going through health crises, though when I see others posting inspirational stories on social media, I can’t help but to wonder how much strife they have actually been through.

FDA Approves Breyanzi for Previously Treated Large B-Cell Lymphoma

June 27th 2022

By Brielle Benyon

The FDA approval of Breyanzi, a CAR-T cell therapy, offers patients with relapsed/refractory lymphoma the opportunity for long-term remission, and hope for a cure, one expert said.

Educated Patient® Metastatic Breast Cancer Summit Updates in Disease Management Panel: June 11, 2022

June 27th 2022

By Kristie L. Kahl

Watch Dr. Suchita Pakkala, Dr. Jane Meisel, Dr. Keerthi Gogineni and Kelly Shanahan discuss updates in disease management during the CURE Educated Patient Metastatic Breast Cancer Summit.